RPRX Market Cap & Key Metrics
Royalty Pharma plc
$58.99
+$2.42(+4.28%)
62
Overall
100
Value
36
Tech
52
Quality
Market Cap
$33.92B
Volume
2.76M
52W Range
$35.23 - $64.38
Target Price
$66.00
RPRX market cap is $33.92B. This page lists Royalty Pharma plc's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RPRX Key Metrics
- Market cap
- $33.92B
- P/E ratio (current-year EPS estimate)
- 11.09
- EPS estimate, current year
- $5.32
- Dividend yield (TTM)
- 1.57%
- Payout ratio
- 48.7%
- EPS growth, 3-year
- +161.59%
- Value score
- 100
- Quality score
- 52
- Technical score
- 36
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.38B | $2.26B | $2.35B | $2.24B | $2.29B |
| EBITDA | $1.63B | $1.56B | $1.89B | $418.02M | $1.43B |
| EPS | $1.79 | $1.92 | $2.54 | $0.10 | $1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $58.99 | +4.3% | 2.76M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |